New drug shows promise for rare gut disorder

NCT ID NCT05214768

Summary

This Phase 3 study tested an investigational drug called CC-93538 for adults and adolescents in Japan with eosinophilic gastroenteritis, a rare inflammatory gut disease. The trial aimed to see if the drug could reduce gut inflammation and improve symptoms like stomach pain, heaviness, and diarrhea over 48 weeks. Researchers compared the drug against a placebo in 48 participants to measure safety and effectiveness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EOSINOPHILIC GASTROENTERITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Local Institution - 001

    Setagaya-ku, Tokyo, 157-8535, Japan

  • Local Institution - 002

    Osaka, 545-8586, Japan

  • Local Institution - 0025

    Tsu, Mie-ken, 514-8507, Japan

  • Local Institution - 003

    Yamagata, 990-9585, Japan

  • Local Institution - 004

    Kobe, 650-0017, Japan

  • Local Institution - 005

    Shibukawa, 377-8577, Japan

  • Local Institution - 006

    Nagoya, 454-8509, Japan

  • Local Institution - 007

    Bunkyo-ku, Tokyo, 113-8603, Japan

  • Local Institution - 008

    Niigata, 951-8510, Japan

  • Local Institution - 009

    Nishinomiya, Hyōgo, 663-8501, Japan

  • Local Institution - 010

    Akita, 010-8543, Japan

  • Local Institution - 011

    Maebashi, 371-8511, Japan

  • Local Institution - 012

    Ōgaki, 503-8502, Japan

  • Local Institution - 013

    Nagaoka, 940-2085, Japan

  • Local Institution - 015

    Hiroshima, 734-8551, Japan

  • Local Institution - 016

    Nagasaki, 852-8501, Japan

  • Local Institution - 017

    Hirosaki, 036-8545, Japan

  • Local Institution - 018

    Kagoshima, 890-8520, Japan

  • Local Institution - 019

    Tokyo, 108-8329, Japan

  • Local Institution - 020

    Kitakyushu, 802-8561, Japan

  • Local Institution - 021

    Nagoya, 467-8602, Japan

  • Local Institution - 022

    Himeji-shi, Hyōgo, 670-8560, Japan

  • Local Institution - 023

    Sendai, Miyagi, 982-8502, Japan

  • Local Institution - 024

    Gifu, Gifu, 5011194, Japan

  • Local Institution - 025

    Tsu, Mie-ken, 514-8507, Japan

Conditions

Explore the condition pages connected to this study.